PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
Abstract Background Heterogeneity in bladder cancer results in variable clinical outcomes, posing challenges for clinical management of this malignancy. Recent studies suggest both tumor suppressive and oncogenic role of PPARγ in bladder cancer. The fuction of PPARγ signaling pathway in modulating c...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2019-03-01
|
| סדרה: | BMC Cancer |
| נושאים: | |
| גישה מקוונת: | http://link.springer.com/article/10.1186/s12885-019-5426-6 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
